Iambic Therapeutics, Inc. financial statements
Iambic Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 9.43M | EODHD |
| Net income | −USD 77.3M | EODHD |
| Cash and equivalents | USD 180.54M | EODHD |
Iambic Therapeutics, Inc. financials on 6ix · Iambic Therapeutics, Inc. on 6ix